Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis
Aghaei A, Gholami J, Sangchooli A, Rostam-Abadi Y, Olamazadeh S, Ardeshir M, Baheshmat S, Shadloo B, Taj M, Saeed K, Rahimi-Movaghar A. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis. The Lancet Global Health 2023, 11: e1225-e1237. PMID: 37474230, DOI: 10.1016/s2214-109x(23)00267-x.Peer-Reviewed Original ResearchConceptsPrevalence of injection drug useInjection drug usePrevalence of HIVHepatitis B virusHepatitis C virusB virusC virusMeta-analysisSystematic reviewHepatitis C virus infection ratesEastern Mediterranean RegionCharacteristics of peopleDrug useHIV infection ratesOpioid agonist treatmentInfection rateProgramme servicesPopulation size of peopleHepatitis CAgonist treatmentHarm reduction servicesHepatitis BWHO Eastern Mediterranean RegionWeb of ScienceProvision of servicesDrug use, drug use disorders, and treatment services in the Eastern Mediterranean region: a systematic review
Rostam-Abadi Y, Gholami J, Jobehdar M, Ardeshir M, Aghaei A, Olamazadeh S, Taj M, Saeed K, Mojtabai R, Rahimi-Movaghar A. Drug use, drug use disorders, and treatment services in the Eastern Mediterranean region: a systematic review. The Lancet Psychiatry 2023, 10: 282-295. PMID: 36848914, DOI: 10.1016/s2215-0366(22)00435-7.Peer-Reviewed Original ResearchConceptsDrug use disordersEastern Mediterranean RegionDrug useTreatment servicesUse disorderIncreasing global public health concernCost-effective carePrevalence of drug use disordersGlobal public health concernPublic health concernPrevalence of drug useGrey literaturePatterns of drug useOpioid agonist treatmentEvidence-basedSystematic reviewTreatment coverageHealth concernAgonist treatmentRegional levelYoung peoplePrevalenceOnline databasesDrugLimited data